Christopher Keenan
Investor Relations Contact chez PLIANT THERAPEUTICS, INC.
Profil
Christopher Keenan is currently the VP-Investor Relations & Corporate Communications at Pliant Therapeutics, Inc. Prior to this, he was the Vice President-Investor Relations & Communications at CytomX Therapeutics, Inc. from 2018 to 2020.
He completed his undergraduate degree at Kenyon College.
Postes actifs de Christopher Keenan
| Sociétés | Poste | Début |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | Investor Relations Contact | 01/11/2020 |
Anciens postes connus de Christopher Keenan
| Sociétés | Poste | Fin |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Investor Relations Contact | 01/10/2020 |
Formation de Christopher Keenan
| Kenyon College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PLIANT THERAPEUTICS, INC. | Health Technology |
| CYTOMX THERAPEUTICS, INC. | Health Technology |
